EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States

Harpreet S Bhatia iD, Samantha Hurst iD, Paresh Desai, Wenhong Zhu iD, Calvin Yeang iD

Journal of the American Heart Association · 19.09.2023 · 12 (18)

DOI: 10.1161/jaha.123.031255 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 19.09.2023. Verfasst von Harpreet S Bhatia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine University of California San Diego La Jolla CA. Hauptthemen laut MEDLINE: Myocardial Ischemia, Aortic Valve Stenosis. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite its high prevalence and clinical significance, clinical measurement of lipoprotein(a) is rare but has not been systematically quantified. We assessed the prevalence of lipoprotein(a) testing overall, in those with various cardiovascular disease (CVD) conditions and in those undergoing cardiac testing across 6 academic medical centers associated with the University of California, in total and by year from 2012 to 2021. Methods and Results In this observational study, data from the University of California Health Data Warehouse on the number of individuals with unique lipoprotein(a) testing, unique CVD diagnoses (using International Classification of Diseases, Tenth Revision [ ICD‐10 ], codes), and other unique cardiac testing were collected. The proportion of total individuals, the proportion of individuals with a given CVD diagnosis, and the proportion of individuals with a given cardiac test and lipoprotein(a) testing any time during the study period were calculated. From 2012 to 2021, there were 5 553 654 unique adults evaluated in the University of California health system, of whom 18 972 (0.3%) had lipoprotein(a) testing. In general, those with lipoprotein(a) testing were more likely to be older, men, and White race, with a greater burden of CVD. Lipoprotein(a) testing was performed in 6469 individuals with ischemic heart disease (2.9%), 836 with aortic stenosis (3.1%), 4623 with family history of CVD (3.3%), 1202 with stroke (1.7%), and 612 with coronary artery calcification (6.1%). For most conditions, the prevalence of testing in the same year as the diagnosis of CVD was relatively stable, with a small upward trend over time. Lipoprotein(a) testing was performed in 10 753 individuals (1.8%) who had lipid panels, with higher rates with more specialized testing, including coronary computed tomography angiography (6.8%) and apolipoprotein B (63.0%).

Conclusions

Lipoprotein(a) testing persists at low rates, even among those with diagnosed CVD, and remained relatively stable over the study period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial IschemiaAortic Valve StenosisAdultMaleHumansUnited StatesLipoprotein(a)HeartAcademic Medical Centers

Stichwörter der Autor:innen

lipoprotein(a)preventionrisk factorstesting

Substanzen

Lipoprotein(a)

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine University of California San Diego La Jolla CA.
  • Herbert Wertheim School of Public Health and Human Longevity Science University of California San Diego La Jolla CA.
  • Altman Clinical and Translational Research Institute, University of California San Diego La Jolla CA.

ORCID-Profile: Harpreet S Bhatia, Samantha Hurst, Wenhong Zhu, Calvin Yeang

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Bhatia, H. S., Hurst, S., Desai, P., Zhu, W., & Yeang, C. (2023). Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. Journal of the American Heart Association, 12(18). https://doi.org/10.1161/jaha.123.031255

Vancouver

Bhatia HS, Hurst S, Desai P, Zhu W, Yeang C. Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States. Journal of the American Heart Association. 2023;12(18). doi:10.1161/jaha.123.031255

BibTeX
@article{Bhatia2023,
  author = {Bhatia, Harpreet S and Hurst, Samantha and Desai, Paresh and Zhu, Wenhong and Yeang, Calvin},
  title = {Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {18},
  doi = {10.1161/jaha.123.031255}
}
Kostenlos starten →